Mon, December 11, 2023

Yuan Zhi Maintained (ATNM) at Strong Buy with Decreased Target to $16 on, Dec 11th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-16-on-dec-11th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Yuan Zhi of B. Riley Securities, Maintained "Actinium Pharmaceuticals, Inc." (ATNM) at Strong Buy with Decreased Target from $20 to $16 on, Dec 11th, 2023.

Yuan has made no other calls on ATNM in the last 4 months.



There are 2 other peers that have a rating on ATNM. Out of the 2 peers that are also analyzing ATNM, 0 agree with Yuan's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Yuan


  • Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Thursday, September 7th, 2023
  • Morten Herholdt of "HSBC" Initiated at Strong Buy and Held Target at $12 on, Wednesday, September 6th, 2023